Tirzepatide Dosing Calculator
Tirzepatide: FDA-approved dual GIP/GLP-1 agonist with up to 22.5% weight loss.
Pre-filled with the most-reported community reconstitution protocol for Tirzepatide. See how 1 mL and 2 mL of bacteriostatic water change concentration and syringe-draw volume, then adjust the calculator below for your own vial.
Quick answer · Community-reported standard
A 15 mg vial of Tirzepatide reconstituted with 2 mL of bacteriostatic water yields a concentration of 7.50 mg/mL. At that concentration, a 2.5 mg dose of Tirzepatide equals 33.3 units on a U-100 insulin syringe (0.333 mL). Tirzepatide is typically administered once weekly via subcutaneous.
Tirzepatide reconstitution: 1 mL vs 2 mL bac water
Bacteriostatic water volume is flexible. Less water means higher concentration and smaller injection volumes; more water means lower concentration and easier dose precision. Both options below are valid for a 15 mg vial.
| BAC water added | Concentration | Volume per 2.5 mg dose | Draw on U-100 syringe (units) |
|---|---|---|---|
| 1 mL | 15.00 mg/mL | 0.167 mL | 16.7 units |
| 2 mL | 7.50 mg/mL | 0.333 mL | 33.3 units |
Calculate your Tirzepatide dose
Alternative Tirzepatide protocols
Beyond the default above, Tirzepatide is also reported in the following protocols. Use these as starting points and recalculate with the tool above.
Compounded Tirzepatide Protocol
Community- Dose
- 2.5-15 mg
- Frequency
- Once weekly
- Duration
- Ongoing
- Route
- Subcutaneous
Uses compounded vials (various concentrations); requires dose calculator tools like Fat Scientist; community reports dosing in units rather than mg
Moderate Maintenance Protocol
Community- Dose
- 7.5-10 mg
- Frequency
- Once weekly
- Duration
- Ongoing
- Route
- Subcutaneous
Many community members stabilize at 7.5-10 mg rather than escalating to maximum 15 mg dose; reports adequate weight loss with fewer GI side effects
Split-Dose Protocol
Community- Dose
- 5-15 mg (split into 2 injections)
- Frequency
- 2 times weekly (splitting weekly dose)
- Duration
- Ongoing
- Route
- Subcutaneous
Some users split their weekly dose into two injections 3-4 days apart to maintain more consistent drug levels and reduce peak-related side effects
Type 2 Diabetes (Mounjaro)
Clinical- Dose
- Start 2.5 mg weekly SC for 4 weeks, then escalate to 5 mg weekly. May increase by 2.5 mg increments every 4 weeks to maximum 15 mg weekly.
- Frequency
- Once weekly subcutaneous injection
- Duration
- Ongoing; long-term maintenance therapy
2.5 mg is the starting dose for GI tolerability, not a therapeutic dose. Minimum therapeutic dose is 5 mg. Dose escalation: 2.5 mg -> 5 mg -> 7.5 mg -> 10 mg -> 12.5 mg -> 15 mg. Each increase after at least 4 weeks.
Weight Management (Zepbound)
Clinical- Dose
- Start 2.5 mg weekly SC for 4 weeks, then escalate to 5 mg weekly. May increase by 2.5 mg increments every 4 weeks. Target maintenance dose is typically 10 mg or 15 mg weekly.
- Frequency
- Once weekly subcutaneous injection
- Duration
- Ongoing; long-term weight management
Same escalation schedule as Mounjaro. Higher maintenance doses (10-15 mg) generally needed for maximal weight loss efficacy. If patient does not tolerate a dose increase, consider maintaining current dose or returning to previously tolerated dose.
Tirzepatide reconstitution & storage
Tirzepatide is supplied as a pre-filled, single-dose pen device (Mounjaro KwikPen or Zepbound pen). No reconstitution, mixing, or dilution is required. Each pen contains a fixed dose and is used once then discarded. Available strengths: 2.5 mg/0.5 mL, 5 mg/0.5 mL, 7.5 mg/0.5 mL, 10 mg/0.5 mL, 12.5 mg/0.5 mL, and 15 mg/0.5 mL.
Store refrigerated at 2-8 degrees C (36-46 degrees F) in the original carton to protect from light. Do not freeze. If needed, unopened pens may be stored at room temperature up to 30 degrees C (86 degrees F) for a maximum of 21 days. Discard if exposed to temperatures above 30 degrees C or if the 21-day room temperature window is exceeded.
Tirzepatide dosing FAQ
How much bacteriostatic water should I add to a 15 mg vial of Tirzepatide?
The community standard is 2 mL of bacteriostatic water for a 15 mg Tirzepatide vial. That gives a concentration of 7.50 mg/mL, so a 2.5 mg dose is 33.3 units on a U-100 insulin syringe. Adding 1 mL instead doubles the concentration to 15.00 mg/mL and halves the draw to 16.7 units. Less water = smaller injection volume but harder to measure precisely.
How many syringe units is a 2.5 mg dose of Tirzepatide?
On a standard U-100 insulin syringe, a 2.5 mg dose of Tirzepatide is 33.3 units when the 15 mg vial is reconstituted with 2 mL of bacteriostatic water (7.50 mg/mL). If you use 1 mL of bac water instead, draw 16.7 units (15.00 mg/mL).
What is the standard Tirzepatide dose?
Community-reported protocols for Tirzepatide typically use 2.5 mgâ15 mg once weekly via Subcutaneous. 2.5 mg is a common starting dose. Mirrors FDA-approved schedule: 2.5 mg x4 weeks, 5 mg x4 weeks, 7.5 mg x4 weeks, 10 mg x4 weeks, 12.5 mg x4 weeks, then 15 mg maintenance
How long does a vial of Tirzepatide last at 2.5 mg once weekly?
A 15 mg vial of Tirzepatide contains roughly 6 doses at 2.5 mg per injection. At once weekly dosing, that is approximately 42 days (about 6 weeks) of supply per vial. Reconstituted Tirzepatide should generally be used within 28 days when refrigerated.
Where do you inject Tirzepatide?
Tirzepatide is typically injected subcutaneous. Common sites reported in the literature and by users include: Abdomen (at least 2 inches from navel), Front of thigh (middle third), Upper arm (back, upper outer area -- may require assistance). Rotate sites with each injection to reduce localized irritation.
Can I use sterile water instead of bacteriostatic water for Tirzepatide?
Bacteriostatic water (containing 0.9% benzyl alcohol as a preservative) is strongly preferred for multi-dose vials like Tirzepatide because it inhibits microbial growth and lets a single vial be used over multiple weeks. Sterile water has no preservative and should generally be reserved for single-use preparations only.
More on Tirzepatide
Tirzepatide overview
Mechanism of action, primary uses, and research summary
Tirzepatide dosing protocols
Full clinical and research-based dosing reference
Tirzepatide community protocols
Real-world usage patterns from peptide communities
Tirzepatide side effects
Reported adverse effects and safety considerations
Compare Tirzepatide with
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.